Articles

Pharma Industry Leaders Views on Trends and Innovations of 2019 and Predictions for 2020. The Pharmaceutical Industry has been witness to an enhanced outlook in 2019. There have been significant developments and new avenue evolutions which have changed the way...

Early phase bioequivalence studies are/can be conducted on all USFDA Orange book approved list of dosage forms based on submission requirements by pharmaceutical companies This has been a market trend for more than 2 decades. USFDA Orange book lists nearly...

As a noticeable shift occurs in the pharmaceutical industry from blockbuster drugs to smaller patient populations, there is an increased focus on targeted therapies in specialized areas, such as oncology, where potent compounds serve a key role in patient...

Pharmaceutical manufacturers have a duty to deliver consistently safe and effective medicines, and a fundamental part of this is ensuring products do not contain harmful biological contaminants. One approach that is widely used to guarantee drugs are free from...

An ageing population, patent expirations, growth of disease prevalence, and expensive breakthrough therapies are driving demand for the development of many new pharmaceutical products. These growing pressures mean that pharmaceutical developers are faced with rising R&D costs and the...

With a central focus on human safety, high quality standards for drug products are upheld worldwide through various drug agencies. In order to ensure that drug products intended for human use fulfil the safety needs of patients, regulatory approval...

As Asia’s healthcare systems mature, demand for the latest bio-pharmaceutical medicines is soaring. Most of these medicines are highly sensitive to temperature, meaning reliable cold chain services are crucial for effectively deploying biopharma across the region. And the need for...